Bearish
Roivant Sciences (ROIV) CEO sells 289,774 shares around $29
Roivant Sciences CEO Matthew Gline reported an open-market sale of 289,774 common shares at a weighted average price of $29.16 per share, totaling app...
Bearish
Roivant Sciences CEO Matthew Gline reported an open-market sale of 289,774 common shares at a weighted average price of $29.16 per share, totaling app...